Sculptor Capital LP Esperion Therapeutics, Inc. Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.81 - $11.92 $639,249 - $1.58 Million	-132,900 Reduced 74.08%	46,500 $233,000
Q3 2020 Nov 12, 2020	BUY	$31.18 - $52.71 $1.44 Million - $2.43 Million	46,100 Added 34.58%	179,400 $6.67 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $2.21 Million - $3.78 Million	73,600 Added 123.28%	133,300 $6.84 Million
Q2 2018 Aug 13, 2018	BUY	$36.2 - $76.4 $2.16 Million - $4.56 Million	59,700 New	59,700 $2.34 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.